STOCK TITAN

Henry Schein Received Validation of Net-Zero Science-Based Targets

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

Henry Schein (Nasdaq: HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has received validation for its net-zero science-based emissions reduction targets from the Science Based Targets initiative (SBTi).

The company's near-term commitments include:

  • 42% reduction in absolute scope 1 GHG emissions by 2030 (2022 base year)
  • Increasing renewable electricity sourcing from 0% to 100% by 2030
  • 51.6% reduction in scope 3 GHG emissions per million USD value added by 2030

For long-term net-zero targets by 2050, Henry Schein commits to:

  • 90% reduction in absolute scope 1 GHG emissions
  • Maintaining 100% renewable electricity sourcing
  • 97% reduction in scope 3 GHG emissions per million USD value added

Henry Schein (Nasdaq: HSIC), il principale fornitore di soluzioni sanitarie per professionisti dentali e medici, ha ricevuto la validazione dei suoi obiettivi di riduzione delle emissioni basati su scienza e net-zero dall'iniziativa Science Based Targets (SBTi).

I compromessi a breve termine dell'azienda includono:

  • riduzione del 42% delle emissioni di gas serra assolute di ambito 1 entro il 2030 (anno base 2022)
  • aumento della fornitura di elettricità rinnovabile dallo 0% al 100% entro il 2030
  • riduzione del 51,6% delle emissioni di gas serra di ambito 3 per milione di USD di valore aggiunto entro il 2030

Per gli obiettivi net-zero a lungo termine entro il 2050, Henry Schein si impegna a:

  • riduzione del 90% delle emissioni di gas serra assolute di ambito 1
  • mantenere una fornitura di elettricità rinnovabile al 100%
  • riduzione del 97% delle emissioni di gas serra di ambito 3 per milione di USD di valore aggiunto

Henry Schein (Nasdaq: HSIC), el principal proveedor de soluciones de atención médica para profesionales dentales y médicos, ha recibido la validación de sus objetivos de reducción de emisiones netas basadas en la ciencia por parte de la iniciativa Science Based Targets (SBTi).

Los compromisos a corto plazo de la compañía incluyen:

  • reducción del 42% en las emisiones absolutas de gases de efecto invernadero de alcance 1 para 2030 (año base 2022)
  • aumentar el suministro de electricidad renovable del 0% al 100% para 2030
  • reducción del 51,6% en las emisiones de gases de efecto invernadero de alcance 3 por cada millón de USD de valor agregado para 2030

Para los objetivos netos cero a largo plazo para 2050, Henry Schein se compromete a:

  • reducción del 90% en las emisiones absolutas de gases de efecto invernadero de alcance 1
  • mantener un suministro de electricidad renovable del 100%
  • reducción del 97% en las emisiones de gases de efecto invernadero de alcance 3 por cada millón de USD de valor agregado

헨리 샤인 (Nasdaq: HSIC), 치과 및 의료 전문가를 위한 의료 솔루션의 주요 제공업체는 과학 기반 목표 이니셔티브(SBTi)로부터 탄소 중립 과학 기반 배출 감소 목표에 대한 검증을 받았습니다.

회사의 단기 약속에는:

  • 2030년까지 절대 범위 1 온실가스 배출량을 42% 줄이는 것 (2022년 기준 연도)
  • 2030년까지 재생 가능 전력 공급을 0%에서 100%로 증가시키는 것
  • 2030년까지 백만 달러의 부가 가치당 범위 3 온실가스 배출량을 51.6% 줄이는 것

2050년까지의 장기 탄소 중립 목표에 대해 헨리 샤인은 다음과 같이 약속합니다:

  • 절대 범위 1 온실가스 배출량을 90% 줄이는 것
  • 100% 재생 가능 전력 공급 유지
  • 백만 달러의 부가 가치당 범위 3 온실가스 배출량을 97% 줄이는 것

Henry Schein (Nasdaq: HSIC), le principal fournisseur de solutions de santé pour les praticiens dentaires et médicaux, a reçu la validation de ses objectifs de réduction des émissions basés sur la science et de zéro net par l'initiative Science Based Targets (SBTi).

Les engagements à court terme de l'entreprise incluent :

  • réduction de 42 % des émissions absolues de GES de portée 1 d'ici 2030 (année de référence 2022)
  • augmentation de l'approvisionnement en électricité renouvelable de 0 % à 100 % d'ici 2030
  • réduction de 51,6 % des émissions de GES de portée 3 par million de dollars de valeur ajoutée d'ici 2030

Pour les objectifs à long terme de zéro net d'ici 2050, Henry Schein s'engage à :

  • réduction de 90 % des émissions absolues de GES de portée 1
  • maintenir un approvisionnement en électricité renouvelable à 100 %
  • réduction de 97 % des émissions de GES de portée 3 par million de dollars de valeur ajoutée

Henry Schein (Nasdaq: HSIC), der führende Anbieter von Gesundheitslösungen für Zahn- und Medizinpraktiker, hat die Validierung seiner wissenschaftlich fundierten Emissionsreduktionsziele für Netto-Null von der Science Based Targets Initiative (SBTi) erhalten.

Die kurzfristigen Verpflichtungen des Unternehmens umfassen:

  • Reduzierung der absoluten Treibhausgasemissionen der Kategorie 1 um 42% bis 2030 (Basisjahr 2022)
  • Erhöhung des Anteils erneuerbarer Elektrizität von 0% auf 100% bis 2030
  • Reduzierung der Treibhausgasemissionen der Kategorie 3 um 51,6% pro Million USD Mehrwert bis 2030

Für die langfristigen Netto-Null-Ziele bis 2050 verpflichtet sich Henry Schein zu:

  • Reduzierung der absoluten Treibhausgasemissionen der Kategorie 1 um 90%
  • Beibehaltung einer 100%igen Versorgung mit erneuerbarer Elektrizität
  • Reduzierung der Treibhausgasemissionen der Kategorie 3 um 97% pro Million USD Mehrwert

Positive
  • None.
Negative
  • None.

Company Commits to Science-Based Targets to Guide Pathway for Achieving Net-Zero Emissions by 2050

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Science Based Targets initiative (SBTi) has approved the Company’s near-term and long-term science-based emissions reduction targets and has verified Henry Schein’s net-zero science-based target by 2050.

“Having joined the Business Ambition for 1.5⁰C initiative in 2021, Henry Schein is pleased to fulfill our commitment to set net-zero emissions reduction targets. Sustainability is deeply rooted in our corporate culture, and we understand our role in mitigating our environmental impact, as climate change is one of today’s most important sustainability issues,” says Jennifer Kim Field, Chief Sustainability Officer at Henry Schein. “Our validated science-based targets bring us closer to realizing our Company’s mission to make the world healthier, together – which needs to be done in collaboration with health care professionals in order to have a healthier planet for healthier people.”

To achieve the near-term science-based targets, Henry Schein, Inc. commits to:

  • Reduce absolute scope 1 GHG (greenhouse gas) emissions by 42% by 2030 from a 2022 base year
  • Increase active annual sourcing of renewable electricity from 0% in 2022 to 100% by 2030
  • Reduce scope 3 GHG emissions by 51.6% per million USD value added (gross profit) by 2030 from a 2022 base year.

The committed net-zero targets include:

  • Reducing absolute scope 1 GHG emissions by 90% by 2050 from a 2022 base year
  • Continuing active annual sourcing of 100% renewable electricity through 2030
  • Reducing scope 3 GHG emissions by 97% per million USD value added (gross profit) by 2050 from a 2022 base year.

To learn more about Henry Schein’s sustainability and corporate citizenship efforts and to view the Company’s 2023 CARES report, please visit www.henryschein.com/corporatecitizenship.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

Stefanie Fleige

Director, Corporate Media Relations – EMEA, Henry Schein

Email: Stefanie.Fleige@henryschein.de

Phone: +49 172 6433548



Lauren DelGuidice

Senior Corporate Media Relations Specialist – North America, Henry Schein

Email: Lauren.DelGuidice@henryschein.com

Phone: +1 631-479-7309

Source: Henry Schein, Inc.

FAQ

What are Henry Schein's (HSIC) specific emission reduction targets for 2030?

By 2030, HSIC commits to 42% reduction in scope 1 emissions, 100% renewable electricity sourcing, and 51.6% reduction in scope 3 emissions per million USD value added from 2022 baseline.

How much will HSIC reduce its greenhouse gas emissions by 2050?

HSIC targets 90% reduction in scope 1 emissions and 97% reduction in scope 3 emissions per million USD value added by 2050, while maintaining 100% renewable electricity usage.

When did Henry Schein join the Business Ambition for 1.5°C initiative?

Henry Schein joined the Business Ambition for 1.5°C initiative in 2021.

What is HSIC's current renewable electricity usage and future target?

HSIC currently uses 0% renewable electricity (2022) and aims to increase this to 100% by 2030.

Has the Science Based Targets initiative (SBTi) validated HSIC's emission targets?

Yes, SBTi has approved both HSIC's near-term and long-term science-based emissions reduction targets, including their net-zero target by 2050.
Henry Schein

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Stock Data

7.78B
109.28M
1.06%
115.73%
4.67%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE